Phosphodiesterase 4 inhibitors, including N-substituted diarylamine analogs

Details for Australian Patent Application No. 2004303855 (hide)

Owner Memory Pharmaceuticals Corporation F. Hoffmann-La Roche AG

Inventors Kuester, Erik; Caroon, Joan; Hopper, Allen; Labadie, Sharada; Tehim, Ashok; Schumacher, Richard; Dunn, Robert; Talamas, Francisco; Renau, Thomas E.

Agent Cullen & Co

Pub. Number AU-A-2004303855

PCT Pub. Number WO2005/061458

Priority 60/528,486 11.12.03 US

Filing date 10 December 2004

Wipo publication date 7 July 2005

International Classifications

C07D 213/74 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 213/75 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 277/28 (2006.01) Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 405/12 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 405/14 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

Event Publications

29 June 2006 PCT application entered the National Phase

  PCT publication WO2005/061458 Priority application(s): WO2005/061458

7 July 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004303856-Process for preparing hexahydropyrimido[1,2-A]azepine-2-carboxylates and related compounds

2004303848-Detection of CD20 in transplant rejection